InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Cullinan Therapeutics, Inc.

CGEM Clue Score48
United States Fiscal year ends December CIK 0001789972 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

34
Insider
Date
Role
Action
Shares
Price
Amount
Jennifer Michaelson
8 Sep 2026
Chief Scientific Officer
Sold after exercise
8,000
$21.57
$172.56K
Jennifer Michaelson
13 Aug 2026
Chief Scientific Officer
Sold after exercise
30,000
$20.26
$607.80K
Jennifer Michaelson
6 Jul 2026
Chief Scientific Officer
Sold after exercise
8,000
$17.82
$142.56K
Jennifer Michaelson
5 May 2026
Chief Scientific Officer
Sold after exercise
200
$15.58
$3.12K
Jennifer Michaelson
5 May 2026
Chief Scientific Officer
Sold after exercise
7,800
$14.60
$113.88K
Jennifer Michaelson
5 Mar 2026
Chief Scientific Officer
Sold after exercise
8,000
$15.68
$125.44K
Jennifer Michaelson
20 Feb 2026
Chief Scientific Officer
Sold after exercise
8,000
$14.30
$114.40K
Jennifer Michaelson
20 Feb 2026
Chief Scientific Officer
Sold after exercise
3,742
$13.62
$50.97K
Jennifer Michaelson
7 May 2024
Chief Scientific Officer
Sold after exercise
5,606
$30.06
$168.52K
Jennifer Michaelson
6 May 2024
Chief Scientific Officer
Sold after exercise
20,277
$28.54
$578.71K
Jennifer Michaelson
6 May 2024
Chief Scientific Officer
Sold after exercise
37,723
$27.82
$1.05M
Corrine Savill
1 Feb 2024
Chief Business Officer
Sold after exercise
40,000
$16.18
$647.20K
Corrine Savill
29 Jan 2024
Chief Business Officer
Sold after exercise
40,000
$14.09
$563.60K
Corrine Savill
23 Jan 2024
Chief Business Officer
Sold after exercise
21,316
$12.46
$265.60K
Corrine Savill
22 Jan 2024
Chief Business Officer
Sold after exercise
4,125
$12.02
$49.58K
Corrine Savill
22 Jan 2024
Chief Business Officer
Sold after exercise
14,559
$12.18
$177.33K
Jennifer Michaelson
7 Jun 2023
Chief Development Officer
Sold after exercise
100
$12.40
$1.24K
Jennifer Michaelson
6 Jun 2023
Chief Development Officer
Sold after exercise
11,900
$12.31
$146.49K
Jennifer Michaelson
25 Nov 2022
See Remarks
Sold after exercise
4,000
$13.30
$53.20K
Jennifer Michaelson
27 Sep 2022
See Remarks
Sold after exercise
4,000
$12.40
$49.60K
Jennifer Michaelson
8 Aug 2022
Chief Development Officer
Sold after exercise
1,385
$15.01
$20.79K
Jennifer Michaelson
25 Jul 2022
Chief Development Officer
Sold after exercise
8,000
$14.51
$116.08K
Jennifer Michaelson
18 Oct 2021
See Remarks
Sold after exercise
400
$23.61
$9.44K
Jennifer Michaelson
18 Oct 2021
See Remarks
Sold after exercise
204
$22.40
$4.57K
Jennifer Michaelson
18 Oct 2021
See Remarks
Sold after exercise
3,396
$21.10
$71.66K
Jeffrey Trigilio
15 Oct 2021
Chief Financial Officer
Sold after exercise
8,000
$25.00
$200.00K
Jennifer Michaelson
20 Sep 2021
See Remarks
Sold after exercise
800
$25.20
$20.16K
Jennifer Michaelson
20 Sep 2021
See Remarks
Sold after exercise
3,200
$24.34
$77.89K
Jeffrey Trigilio
8 Sep 2021
Chief Financial Officer
Sold after exercise
9,513
$28.85
$274.45K
Jeffrey Trigilio
8 Sep 2021
Chief Financial Officer
Sold after exercise
5,487
$27.83
$152.70K
Patrick Baeuerle
8 Sep 2021
See Remarks
Sold after exercise
11,000
$28.45
$312.95K
Jennifer Michaelson
18 Aug 2021
See Remarks
Sold after exercise
1,137
$28.07
$31.92K
Jennifer Michaelson
18 Aug 2021
See Remarks
Sold after exercise
2,863
$27.50
$78.73K
Patrick Baeuerle
10 Aug 2021
See Remarks
Sold after exercise
11,000
$27.00
$297.00K
Show all 213 transactions →

What was left out

Form 4 filings counted 220
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 21
Sales on a Rule 10b5-1 plan 12
Sales straight out of an exercise 34
Sales at will 139
Transactions with no price 0
Shares from compensation/vesting 31,067,955
Sales filed before the plan box existed 81
History held since 11 Jan 2021